An Ohio-based healthcare company just announced that it is initiating a second production run of the first CBD nutraceuticals products that the company recently introduced. This demand-driven response had shares of PAO Group Inc. (OTCPK:PAOG) trading higher as we head into the second half of the trading session
PAO Group is the United States-based holding company. It seeks to develop, acquire, partner, or participate in, companies and concepts in the development and launch of alternative medicine clinics focused on non-traditional patient care solutions. The range of treatment solutions includes cannabis, acupuncture, chiropractic, biofeedback, and other solutions depending on patient needs. The group primarily operates from the United States of America.
Traders were bullish on the news as shares popped up to $0.005/share (+6.38%) at the session high. This move is a strong continuation of the success this stock has had over the last few months.
Recent Comments